News

November 14, 2019November 14, 2019

Enrollment Completed for Phase 3 Trial Testing Provenge in Prostate Cancer Patients on Active Surveillance

News

Dendreon Pharmaceuticals has completed patient enrollment ahead of schedule in an ongoing Phase 3 trial assessing the safety and efficacy of its immunotherapy Provenge (sipuleucel-T) for men with early-stage ... Read more

November 13, 2019

Phase 1 DRGT-45 Trial Doses First Patient With New Oral Formulation of Abiraterone Acetate

News

A Phase 1 clinical trial testing DRGT-45 — a new oral formulation of abiraterone acetate — in men with prostate cancer has dosed its first participant, the treatment’s developer, ... Read more

November 11, 2019

Men with BRCA2 Mutations Should Get Regular PSA Screening, Phase 3 Interim Data Suggest

News

Prostate-specific antigen (PSA) testing — a controversial approach to detecting prostate cancer — spotted the cancer more often, at a younger age, and in more serious forms in men ... Read more

November 7, 2019November 11, 2019

Use of Assisted Reproduction Techniques Linked to Increased Prostate Cancer Risk, Study Suggests

News

Men who father children through assisted reproduction techniques, either in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI), may be at a higher risk of developing prostate cancer, a ... Read more

November 6, 2019

$1.8M NIH Award to Support Work into Robotic System Able to Better Detect Prostate Cancer

News

Haichong Zhang, an assistant professor at Worcester Polytechnic Institute, has been given a Director’s Early Independence Award from the National Institutes of Health (NIH) to support his work in designing ... Read more

November 4, 2019

Veru Completes Enrollment for Zuclomiphene Citrate Trial for ADT-Induced Hot Flashes in PC

News

Veru Healthcare has completed patient enrollment for its Phase 2 clinical trial evaluating the use of zuclomiphene citrate (VERU-944) for the treatment of hot flashes in men receiving hormone ... Read more

October 31, 2019

Prostate Cancer Patients May Benefit from Routine Tumor Genetic Testing, Study Suggests

News

Implementation of routine tumor genetic testing may help identify the approximately 30% of men with metastatic castration-resistant prostate cancer (mCRPC) who may significantly benefit from targeted treatment, namely PARP ... Read more

October 30, 2019

Celebs in Parody Video Urge Support for Movember to Raise Prostate Cancer Awareness

News

In a lighthearted twist on a serious goal of raising awareness and funds for prostate cancer, the Movember Foundation is again encouraging gents to join glitterati in celebrating the ... Read more

October 28, 2019

Targeted Radiation (SBRT) Can Control Prostate Cancer That Has Spread Slightly, Trial Results Suggest

News

Stereotactic body radiation therapy (SBRT) — a form of targeted, high-dose radiation therapy — significantly extends the time without detectable disease progression when given to prostate cancer patients with ... Read more

October 24, 2019October 25, 2019

Prostate Cancer Patients May Safely Skip Radiation Therapy After Surgery, Phase 3 Trial Shows

News

Men with prostate cancer who undergo surgery have similar long-term outcomes whether they receive radiation therapy shortly after the surgery or only when signs of disease recurrence appear, suggesting ... Read more

Pin It on Pinterest